
Kimberly-Clark prepares asset sales to win EU nod for Kenvue deal, sources say
Kimberly-Clark is preparing asset divestments and regulatory concessions to address European Union antitrust concerns regarding its multi-billion-dollar acquisition of Tylenol maker Kenvue. Sources familiar with the matter report that the European Commission is set to formally notify the companies of its preliminary competition concerns. This regulatory notification will determine whether...








